Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  American Journal of Physiology

• Publication date

  1995-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/AJPHEART.1995.269.4.H1370PMID 7485570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• The Role of Bradykinin and Angiotensin Converting Enzyme Inhibitors in Myocardial Protection: A Review of Randomized Control Trials

  2018cites this paper
• Effect of hypoxia on the cardiovascular sphingolipid system

  2017cites this paper
• Bradykinin in ischemic conditioning-induced tissue protection: Evidences and possible mechanisms.

  2015cites this paper
• An investigation into the effect of hypoxia in the uterus : does hypoxic preconditioning occur?

  2013cites this paper
• The Effects of Decreased Cardiac CapZ Protein on the Myocardial Response to Stress

  2012cites this paper
• Bradykinin does not mediate remote ischaemic preconditioning or ischaemia-reperfusion injury in vivo in man

  2011cites this paper
• The kallikrein-kinin system as a regulator of cardiovascular and renal function.

  2011cites this paper
• Renin angiotensin system and cardiovascular disease

  2010cites this paper
• Role of MicroRNAs in Cardiac Preconditioning

  2010cites this paper
• A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept

  2010cites this paper
• Kinins and Cardiovascular Disease

  2009cites this paper
• The anti-inflammatory effect of bradykinin preconditioning in coronary artery bypass grafting (bradykinin and preconditioning)

  2009cites this paper
• Participation of kallikrein-kinin system in different pathologies.

  2008cites this paper
• Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection.

  2007cites this paper
• Evidence for enhanced eNOS function in coronary microvessels during the second window of protection.

  2007cites this paper
• Pharmacological Preconditioning in Coronary Artery Bypass Surgery

  2006cites this paper
• Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.

  2005cites this paper
• Chapter 20 – The Kallikrein-Kinin System as a Regulator of Cardiovascular and Renal Function

  2005cites this paper
• Pharmacological preconditioning with bradykinin affords myocardial protection through NO-dependent mechanisms.

  2005cites this paper
• Bradykinin preconditioning preserves coronary microvascular reactivity during cardioplegia-reperfusion.

  2005cites this paper
• Role of Reactive Oxygen Species in Ischemic Preconditioning of Subcellular Organelles in the Heart

  2004cites this paper
• Myocardial injury and its prevention in the perioperative setting.

  2004cites this paper
• Bradykinin and angiotensin-converting enzyme inhibition in cardioprotection.

  2004cites this paper
• Lack of association of a 9 bp insertion/deletion polymorphism within the bradykinin 2 receptor gene with myocardial infarction.

  2004cites this paper
• Bradykinin and angiotensin-converting enzyme inhibition in cardioprotection angiotensin-converting enzyme EXPERIMENTAL

  2004cites this paper
• Role of preconditioning in cardiac surgery

  2004cites this paper
• Effects of ACE Inhibition on Myocardial Apoptosis in an Ischemia–Reperfusion Rat Heart Model

  2003cites this paper
• The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease

  2003cites this paper
• Roles for the kallikrein-kinin system in inflammatory exudation and pain: lessons from studies on kininogen-deficient rats.

  2003cites this paper
• Quinaprilat Reduces Myocardial Infarct Size Involving Nitric Oxide Production and Mitochondrial KATP Channel in Rabbits

  2003cites this paper
• Role of bradykinin in preconditioning and protection of the ischaemic myocardium

  2002cites this paper
• Therapeutic receptor targets of ischemic preconditioning.

  2002cites this paper
• Pharmacological and ischemic preconditioning of the human myocardium: mitoKATP channels are upstream and p38MAPK is downstream of PKC

  2002cites this paper
• Ischemic Preconditioning: Fact or Fantasy?

  2002cites this paper
• Kinins and kinin receptors in the pathogenesis of heart failure

  2002cites this paper
• Gene activity changes in ischemically preconditioned rabbit heart gene: discovery array study.

  2002cites this paper
• Organ preconditioning.

  2001cites this paper
• Long-term angiotensin-converting enzyme and angiotensin I--receptor inhibition in pacing-induced heart failure: effects on myocardial interstitial bradykinin levels.

  2001cites this paper
• Enhanced regional AT(2)-receptor and PKC(epsilon) expression during cardioprotection induced by AT(1)-receptor blockade after reperfused myocardial infarction.

  2001cites this paper
• Clinical applications of ischemic preconditioning: from head to toe.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart.

  2001cites this paper
• Angiotensin II reduces infarct size and has no effect on post‐ischaemic contractile dysfunction in isolated rat hearts

  2001cites this paper
• Enhanced regional AT2-receptor and PKCε expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction

  2001cites this paper
• Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium.

  2001cites this paper
• Pretreatment With Ramiprilat Induces Cardioprotection Against Free Radical Injury In Guinea‐Pig Isolated Heart: Involvement Of Bradykinin, Protein Kinase C And Prostaglandins

  2000cites this paper
• Protein Kinase C in Rat Ventricular Myocardium δ Specific Activation of Anti-Ischemic Effect of a Novel Cardioprotective Agent , JTV 519 , Is Mediated Through

  2000cites this paper
• Infarct Size Limitation by Bradykinin Receptor Activation Is Mediated by the Mitochondrial But Not by the Sarcolemmal KATP Channel

  2000cites this paper
• Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning.

  2000cites this paper
• Mechanisms of ischemic preconditioning effects on Ca(2+) paradox-induced changes in heart.

  2000cites this paper
• Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.

  2000cites this paper
• The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

  2000cites this paper
• Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-isoform of protein kinase C in rat ventricular myocardium.

  2000cites this paper
• Delayed myocardial protection induced by endotoxin does not involve kinin B1‐receptors

  2000cites this paper
• On “Ischemic Preconditioning in Myocardial Revascularization with Intermittent Aortic Cross‐Clamping”

  2000cites this paper
• Bradykinin protects the rabbit heart after cardioplegic ischemia via NO-dependent pathways.

  2000cites this paper
• Preconditioning the Brain and Heart: Implications for Cardiac Surgery

  2000cites this paper
• Kinin B1 receptors and the cardiovascular system: regulation of expression and function

  2000cites this paper
• Calcium preconditioning, but not ischemic preconditioning, bypasses the adenosine triphosphate-dependent potassium (KATP) channel.

  1999cites this paper
• Bradykinin-induced preconditioning in patients undergoing coronary angioplasty.

  1999cites this paper
• Pharmacology and cardiovascular implications of the kinin-kallikrein system.

  1999cites this paper
• Bradykinin pretreatment improves ischemia tolerance of the rabbit heart by tyrosine kinase mediated pathways.

  1999cites this paper
• Interaction of Bradykinin with Angiotensin, Prostacyclin, and Nitric Oxide in Myocardial Preservation a

  1999cites this paper
• Molecular targets of gene therapy.

  1999cites this paper
• Ramipril‐induced delayed myocardial protection against free radical injury involves bradykinin B2 receptor‐NO pathway and protein synthesis

  1998cites this paper
• Beneficial effect of ischemic preconditioning on Ca2+ paradox in the rat heart.

  1998cites this paper
• Tumor necrosis factor in the heart.

  1998cites this paper
• Tumor necrosis factor in the heart.

  1998cites this paper
• Role of kinins in the endothelial protective effect of ischaemic preconditioning

  1998cites this paper
• Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved.

  1998cites this paper
• Bradykinin B2‐receptor‐mediated modulation of membrane currents in guinea‐pig cardiomyocytes

  1998cites this paper
• Ischemic preconditioning: exploring the paradox.

  1998cites this paper
• BRADYKININ MEDIATES MYOCARDIAL ISCHAEMIC PRECONDITIONING AGAINST FREE RADICAL INJURY IN GUINEA‐PIG ISOLATED HEART

  1998cites this paper
• Regulation of protein kinases during postnatal development of rat heart

  1998cites this paper
• A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death.

  1997cites this paper
• Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning.

  1997cites this paper
• Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats.

  1997cites this paper
• Ca2+ as a mediator of ischemic preconditioning.

  1997cites this paper
• Transient ischemia inhibits nonexocytotic release of norepinephrine following sustained ischemia in rat heart: is bradykinin involved?

  1997cites this paper
• Protein kinase C isoform diversity in preconditioning.

  1997cites this paper
• Preischemic bradykinin and ischaemic preconditioning in functional recovery of the globally ischaemic rat heart.

  1997influential citation
• Ischemic preconditioning of the myocardium, role of angiotensin II receptors

  1997cites this paper
• Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning.

  1997cites this paper
• 6. Protein IGnase C - the I(ey-Enzyme in Ischemic Preconditioning?

  1997cites this paper
• Adaptive and maladaptive mechanisms of cellular priming.

  1997cites this paper
• Different preconditioning stimuli invoke disparate electromechanical and energetic responses to global ischemia in rat hearts.

  1997cites this paper
• Protein Kinase C - the Key-Enzyme in Ischemic Preconditioning?

  1997cites this paper
• Signal transduction in ischemic preconditioning.

  1997cites this paper
• Oxidative stress and ischaemia-reperfusion of the heart : a clinical and experimental study

  1997cites this paper
• Integration of Adenosine and Noradrenergic Pathways in Cardiac Preconditioning

  1996cites this paper
• Loss of glycogen during preconditioning is not a prerequisite for protection of the rabbit heart

  1996cites this paper
• The role of protein kinase in C ischemic/reperfused preconditioned isolated rat hearts.

  1996cites this paper
• Cardiac preconditioning with calcium: clinically accessible myocardial protection.

  1996cites this paper
• Myocardial Preconditioning

  1996cites this paper
• Activation of Protein Kinase C is Critical to the Protection of Preconditioning

  1996cites this paper